Analysts expect Novartis Ag to report revenue of 15.21 B for Q4 26, against a range of 13.71 B to 16.72 B. The most recent reported quarter, Q3 26, came in at 14.52 B, a 6.4% beat against the 13.64 B consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 13.15 B | 13.23 B | 14.05 B | 13.91 B | 13.34 B | 13.11 B | 14.41 B | 14.52 B | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 12.99 B | 13.78 B | 14.29 B | 15.27 B | 15.08 B | 13.10 B | 15.56 B | 14.50 B | 16.72 B | 16.19 B | 15.63 B | 16.09 B | 15.83 B | 16.70 B | 18.59 B | 16.46 B | |||||||||
| Low Estimate | 10.92 B | 11.29 B | 11.93 B | 13.98 B | 13.72 B | 12.13 B | 13.80 B | 12.79 B | 13.71 B | 13.50 B | 14.07 B | 13.18 B | 14.37 B | 15.56 B | 15.87 B | 15.42 B | |||||||||
| Consensus Estimate | 11.95 B | 12.53 B | 13.11 B | 14.63 B | 14.40 B | 12.61 B | 14.68 B | 13.64 B | 15.21 B | 14.85 B | 14.85 B | 14.63 B | 15.10 B | 16.13 B | 17.23 B | 15.94 B |
Analysts expect Novartis Ag to report earnings per share of 2.12 for Q4 26, against a range of 2.02 to 2.22. The most recent reported quarter, Q3 26, came in at 2.46, a 11.8% beat against the 2.20 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.98 | 2.28 | 2.42 | 2.25 | 2.03 | 1.99 | 2.41 | 2.46 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 1.88 | 2.19 | 2.51 | 2.48 | 2.06 | 2.14 | 2.36 | 2.33 | 2.22 | 2.43 | 2.88 | 3.03 | 2.67 | 2.80 | 3.32 | 2.83 | |||||||||
| Low Estimate | 1.62 | 1.79 | 2.29 | 2.24 | 1.74 | 1.92 | 2.22 | 2.07 | 2.02 | 2.01 | 2.52 | 2.49 | 2.33 | 2.54 | 2.72 | 2.59 | |||||||||
| Consensus Estimate | 1.75 | 1.99 | 2.40 | 2.36 | 1.90 | 2.03 | 2.29 | 2.20 | 2.12 | 2.22 | 2.70 | 2.76 | 2.50 | 2.67 | 3.02 | 2.71 |
Pull Wall Street consensus for Novartis Ag (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NVS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NVS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NVS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();